Website traffic from AI agents and bots has eclipsed its human-generated counterpart for the first time, according to Cloudflare, an earlier-than-expected milestone that speaks to AI’s rapid advance ...
CLAYTON, Mo. – A Creve Coeur woman is appearing in St. Louis County Circuit Court Thursday for allegedly using AI to generate nude images of underage children. Alexandra N. Klotz-Copeland was arrested ...
This week, a company called Casimir Inc. emerged from “stealth mode” to announce that it had raised significant funding from venture capitalists willing to roll the dice on free energy. That’s right: ...
Monday - Friday, 11:00 - 12:00 SIN/HK | 0500 - 06:00 CET Samir Kapadia, Managing Principal at Vogel Group, says the first issue that needs to be addressed on the Strait of Hormuz is whether Iran can ...
Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Erik Steiger discusses the operational pain ...
Google just introduced Lyria 3 Pro, an updated version of its AI model that generates songs based on prompts. The biggest improvement here is the ability to make full three-minute songs, up from 30 ...
The Allen Institute for AI is releasing an open-source web agent that can navigate and complete tasks in a browser — letting developers look under the hood to understand what’s happening in ways not ...
OpenAI will combine its web browser, ChatGPT app and Codex app into a singular desktop super app. Fidji Simo, OpenAI's CEO of Applications, will oversee the change with assistance from OpenAI ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Pills, tablets and capsules on world map with charts blue background. International ...
Generate:Biomedicines has earmarked $300 million of its IPO funds to complete a pair of phase 3 asthma trials for its anti-TSLP antibody GB-0895. (Fabrice Cabaud/Stock/Getty Images Plus) ...
Feb 26 (Reuters) - Generate Biomedicines said on Thursday that it raised $400 million in its U.S. initial public offering, pricing shares of the U.S.-based drug developer at $16 each. The offering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results